Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Andrew J. Lewin"'
Autor:
Andrew J Lewin, Juan P Frías
Publikováno v:
Expert Opinion on Pharmacotherapy. 16:781-784
The combination of metformin and a sulfonylurea is commonly used in type 2 diabetes mellitus. Many patients on this combination therapy do not achieve or maintain glycemic targets and require the addition of a third antihyperglycemic agent. Among the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cf26ba49facb6ec59c6d550365f2d5a
https://doi.org/10.1517/14656566.2015.1009445
https://doi.org/10.1517/14656566.2015.1009445
Publikováno v:
Clinical Therapeutics. 35:142-152
Elevated systolic blood pressure (SBP) is an independent risk factor for cardiovascular events and mortality.The goal of this study was to assess whether nebivolol (NEB), a vasodilatory β(1)-selective blocker, is a safe and efficacious monotherapy f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::547de748848a146d4c63e08a6a47cc03
https://doi.org/10.1016/j.clinthera.2012.12.015
https://doi.org/10.1016/j.clinthera.2012.12.015
Autor:
Matthew R. Weir, Andrew J. Lewin
Publikováno v:
Clinical Therapeutics. 30:2354-2365
This was a post hoc subgroup analysis of efficacy and tolerability data from the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations (INCLUSIVE) trial stratified by baseline body mass index (BMI). The BMI subgroup data were also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8158f2216656d93c6a217aff2e4ffe50
https://doi.org/10.1016/j.clinthera.2008.12.018
https://doi.org/10.1016/j.clinthera.2008.12.018
Autor:
Tu T. Nguyen, Steven G. Terra, Xiang Gao, Charles F. Contant, Andrew J. Lewin, Omar L. Francone
Publikováno v:
The American Journal of Cardiology. 102:434-439
The weak peroxisome proliferator activated receptor-alpha (PPAR-alpha) agonists gemfibrozil and fenofibrate achieve only small increases in high-density lipoprotein (HDL) cholesterol. CP-778,875 is a more potent PPAR-alpha agonist developed to produc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80197d19bca458c9b8ebf2f8790c5b49
https://doi.org/10.1016/j.amjcard.2008.03.076
https://doi.org/10.1016/j.amjcard.2008.03.076
Publikováno v:
Clinical Therapeutics. 29:844-855
Metformin is widely used in the management of type 2 diabetes, either as monotherapy or in combination with other oral antihyperglycemic agents such as sulfonylureas and thiazolidinediones. Combination treatment with metformin and sulfonylurea in pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::075504c17bcdbed8171d4305057b9820
https://doi.org/10.1016/j.clinthera.2007.05.013
https://doi.org/10.1016/j.clinthera.2007.05.013
Autor:
Andrew J, Lewin, Juan P, Frías
Publikováno v:
Diabetes Care
OBJECTIVE To investigate the efficacy and tolerability of empagliflozin as add-on to metformin and sulfonylurea in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS Patients inadequately controlled on metformin and sulfonylurea (HbA1c ≥7 t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::671e7868935f4d9c5e77f3fa4d967b8b
https://pubmed.ncbi.nlm.nih.gov/23963895
https://pubmed.ncbi.nlm.nih.gov/23963895
Autor:
Myron H. Weinberger, Gordon H. Williams, Andrew J. Lewin, Scott Krause, Murray Epstein, Bruce Beckerman, Rajiv Patni, Robin Mukherjee
Publikováno v:
Clinical Journal of the American Society of Nephrology. 1:940-951
Previous studies have shown that the selective aldosterone blocker eplerenone, in doses of up to 200 mg/d, reduces albuminuria in patients with type 2 diabetes. This study was conducted to ascertain whether lower doses of eplerenone (50 or 100 mg/d)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::953cff98e7770c9cd2bd40b5c71eee1c
https://doi.org/10.2215/cjn.00240106
https://doi.org/10.2215/cjn.00240106
Autor:
George L. Bakris, Kellie Leight, Gilbert W. Gleim, Santosh Sutradhar, Jonathan C. Fox, Andrew J. Lewin, Laura A. Demopoulos
Publikováno v:
J Clin Hypertens (Greenwich)
The JNC 7 states that persons with blood pressure (BP) more than 20/10 mm Hg above goal should be started on combination drug therapy. This criterion includes patients with BP >160/100 mm Hg and diabetics with hypertension. The goal BP for persons wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10694f0aa5779bb4855734004d388e0a
https://doi.org/10.1111/j.1524-6175.2004.03488.x
https://doi.org/10.1111/j.1524-6175.2004.03488.x
Autor:
Yale B. Mitchel, William Insull, Michael J. Koren, Andrew J. Lewin, Meehyung Cho, Michelle Sidisin, James M. McKenney, Ted Feldman, Debra Kush, Sukrut Shah, Helmut G. Schrott
Publikováno v:
The American Journal of Cardiology. 93:1481-1486
This study assessed whether the co-administration of ezetimibe and simvastatin would be more effective than simvastatin monotherapy in allowing high-risk patients to achieve a low-density lipoprotein (LDL) cholesterol goal of100 mg/dl. Men and women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e28c86a602a73f3d10dd4e6886e39402
https://doi.org/10.1016/j.amjcard.2004.02.059
https://doi.org/10.1016/j.amjcard.2004.02.059
Autor:
Andrew J, Lewin, Dean J, Kereiakes, Steven G, Chrysant, Joseph L, Izzo, Suzanne, Oparil, James, Lee, Victor, Fernandez, Michael, Melino
Publikováno v:
Ethnicitydisease. 24(1)
Evaluate efficacy/safety of olmesartan medoxomil (OM)/amlodipine (AML)/ hydrochlorothiazide (HCTZ) in Hispanic/Latino adults with hypertension.Randomized, double-blind, 12-week, parallel-group study followed by a 40-week open-label extension phase.Cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb58b0be0f3cadce692158f2e1c86d91
https://pubmed.ncbi.nlm.nih.gov/24620447
https://pubmed.ncbi.nlm.nih.gov/24620447